EYA1 In Ear Development And Branchio-Oto-Renal Syndrome
EYA1 耳朵发育与鳃耳肾综合征
基本信息
- 批准号:7210704
- 负责人:
- 金额:$ 40.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-04-15 至 2010-03-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAlternative SplicingAnimal ModelAttentionAuditory systemBranchio-Oto-Renal SyndromeChildCongenital AbnormalityDevelopmentDiagnosisDominant-Negative MutationEarEmbryoGene ExpressionGene Expression AlterationGene MutationGenesGeneticGenetic TranscriptionIndividualInjection of therapeutic agentInvestigationLabyrinthLearningMessenger RNAMethodsModelingMolecularMutationOligonucleotidesOther GeneticsPathogenesisPathway interactionsPatternPhenotypePlayProtein IsoformsProteinsRNA SplicingReportingResearchResearch PersonnelRoleSensoryStagingTestingTissuesTranscriptXenopusXenopus laevisbody systemdeafnesshearing impairmentinsightmRNA Transcript Degradationmalformationmutantprogramsprotein expressionresearch studytool
项目摘要
DESCRIPTION (provided by applicant): Congenital hearing loss affects ~ 1:1000 children, making it one of the most commonly diagnosed sensory birth defects. The long-term objective of this study is to use Xenopus laevis as a vertebrate model organism to investigate the genetic mechanisms of inner ear development and deafness. Targeted alteration of gene expression in Xenopus embryos, which has been successfully used in the investigation of other organ systems, is an ideal method to investigate the developmental dynamics of inner ear formation. We will initially focus on the role of EYA1 in inner ear development, since EYA1 mutations result in branchio-otorenal syndrome (BOR), a common syndromic forms of hearing loss with a unique phenotype that may be reproducible and easily recognizable in a model organism. This study has 3 specific aims: 1) to determine the spatial and temporal developmental expression patterns of EYA1 in the Xenopus laevis inner ear. A comparison will be made of the stage specific expression patterns of both EYA1 mRNA and protein in the inner ear, with specific attention to the presence and functional significance of alternative splicing in EYA1 expression. 2) To perform targeted EYA1 mRNA degradation with modified oligonucleotide injection of Xenopus embryos to determine its molecular and morphologic effects in the developing inner ear. If these experiments result in inner ear abnormalities comparable to that found in BOR, this would indicate haploin sufficiency as a likely mechanism for the development of the BOR phenotype. 3) To model the effects of EYA1 mRNA misexpression by embryo injection experiments involving excess normal message or altered mRNAs corresponding to mutations found in BOR. If inner ear malformations result from inappropriate EYA1 mRNA levels, this would indicate that dominant negative or abnormal protein activity underlies the dominant phenotype of BOR.
描述(由申请人提供):先天性听力损失影响约1:1000的儿童,使其成为最常见的诊断感官出生缺陷之一。本研究的长期目标是利用非洲爪蟾作为脊椎动物模式生物,研究内耳发育和耳聋的遗传机制。在非洲爪蟾胚胎中靶向改变基因表达是研究内耳形成发育动力学的理想方法,已成功应用于其他器官系统的研究。我们最初将重点关注EYA 1在内耳发育中的作用,因为EYA 1突变会导致鳃耳肾综合征(BOR),这是一种常见的听力损失综合征形式,具有独特的表型,在模式生物中可能是可重复且易于识别的。本研究有3个具体的目的:1)确定EYA 1在非洲爪蟾内耳的时空发育表达模式。比较EYA 1 mRNA和蛋白质在内耳中的阶段特异性表达模式,特别注意EYA 1表达中选择性剪接的存在和功能意义。2)目的:应用修饰的寡核苷酸注射技术对非洲爪蟾胚胎进行靶向EYA 1 mRNA降解,以确定其对发育中内耳的分子和形态学影响。如果这些实验导致与BOR中发现的内耳异常相当的内耳异常,则这将表明单倍蛋白充足是BOR表型发展的可能机制。3)通过胚胎注射实验模拟EYA 1 mRNA错误表达的影响,该实验涉及过量的正常信息或与BOR中发现的突变相对应的改变的mRNA。如果内耳畸形是由EYA 1 mRNA水平不适当引起的,这将表明显性负性或异常蛋白活性是BOR显性表型的基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOSE M MANALIGOD其他文献
JOSE M MANALIGOD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOSE M MANALIGOD', 18)}}的其他基金
EYA1 In Ear Development And Branchio-Oto-Renal Syndrome
EYA1 耳朵发育与鳃耳肾综合征
- 批准号:
6908730 - 财政年份:2005
- 资助金额:
$ 40.36万 - 项目类别:
EYA1 In Ear Development And Branchio-Oto-Renal Syndrome
EYA1 耳朵发育与鳃耳肾综合征
- 批准号:
7577350 - 财政年份:2005
- 资助金额:
$ 40.36万 - 项目类别:
EYA1 In Ear Development And Branchio-Oto-Renal Syndrome
EYA1 耳朵发育与鳃耳肾综合征
- 批准号:
7053379 - 财政年份:2005
- 资助金额:
$ 40.36万 - 项目类别:
EYA1 In Ear Development And Branchio-Oto-Renal Syndrome
EYA1 耳朵发育与鳃耳肾综合征
- 批准号:
7383078 - 财政年份:2005
- 资助金额:
$ 40.36万 - 项目类别:
Molecular genetics of familial laryngeal paralysis
家族性喉麻痹的分子遗传学
- 批准号:
6433905 - 财政年份:2002
- 资助金额:
$ 40.36万 - 项目类别:
Molecular genetics of familial laryngeal paralysis
家族性喉麻痹的分子遗传学
- 批准号:
6835712 - 财政年份:2002
- 资助金额:
$ 40.36万 - 项目类别:
Molecular genetics of familial laryngeal paralysis
家族性喉麻痹的分子遗传学
- 批准号:
6621330 - 财政年份:2002
- 资助金额:
$ 40.36万 - 项目类别:
Molecular genetics of familial laryngeal paralysis
家族性喉麻痹的分子遗传学
- 批准号:
7000390 - 财政年份:2002
- 资助金额:
$ 40.36万 - 项目类别:
Molecular genetics of familial laryngeal paralysis
家族性喉麻痹的分子遗传学
- 批准号:
6692162 - 财政年份:2002
- 资助金额:
$ 40.36万 - 项目类别:
相似海外基金
Alternative splicing of Grin1 controls NMDA receptor function in physiological and disease processes
Grin1 的选择性剪接控制生理和疾病过程中的 NMDA 受体功能
- 批准号:
488788 - 财政年份:2023
- 资助金额:
$ 40.36万 - 项目类别:
Operating Grants
RBFOX2 deregulation promotes pancreatic cancer progression through alternative splicing
RBFOX2 失调通过选择性剪接促进胰腺癌进展
- 批准号:
10638347 - 财政年份:2023
- 资助金额:
$ 40.36万 - 项目类别:
Long Noncoding RNA H19 Mediating Alternative Splicing in ALD Pathogenesis
长非编码 RNA H19 介导 ALD 发病机制中的选择性剪接
- 批准号:
10717440 - 财政年份:2023
- 资助金额:
$ 40.36万 - 项目类别:
Using proteogenomics to assess the functional impact of alternative splicing events in glioblastoma
使用蛋白质基因组学评估选择性剪接事件对胶质母细胞瘤的功能影响
- 批准号:
10577186 - 财政年份:2023
- 资助金额:
$ 40.36万 - 项目类别:
Alternative splicing regulation of CLTC in the heart
心脏中 CLTC 的选择性剪接调节
- 批准号:
10749474 - 财政年份:2023
- 资助金额:
$ 40.36万 - 项目类别:
Nitric oxide as a novel regulator of alternative splicing
一氧化氮作为选择性剪接的新型调节剂
- 批准号:
10673458 - 财政年份:2023
- 资助金额:
$ 40.36万 - 项目类别:
Alternative splicing as an evolutionary driver of phenotypic plasticity
选择性剪接作为表型可塑性的进化驱动力
- 批准号:
2884151 - 财政年份:2023
- 资助金额:
$ 40.36万 - 项目类别:
Studentship
Rescuing SYNGAP1 haploinsufficiency by redirecting alternative splicing
通过重定向选择性剪接挽救 SYNGAP1 单倍体不足
- 批准号:
10660668 - 财政年份:2023
- 资助金额:
$ 40.36万 - 项目类别:
CAREER: Mechanotransduction, transcription, and alternative splicing in cell biology
职业:细胞生物学中的机械转导、转录和选择性剪接
- 批准号:
2239056 - 财政年份:2023
- 资助金额:
$ 40.36万 - 项目类别:
Continuing Grant
Investigating the role of alternative splicing in the islets of Langerhans in developing diabetes.
研究朗格汉斯岛中选择性剪接在糖尿病发生中的作用。
- 批准号:
468851650 - 财政年份:2022
- 资助金额:
$ 40.36万 - 项目类别:
Research Grants